OVER 70 YEARS OF COMBINED LEADERSHIP EXPERIENCE
Starting in Statistical Programming and rising to Senior Executives, we have accumulated a wealth of experience. We share a passion for helping individuals and teams reach their full potential.
Irving Dark
Irving is an International Operations and Business Development Executive with a proven track record for establishing and growing specialty Clinical Research Organizations. He is a biometrics Subject Matter Expert with over 30 years of industry experience guiding drug, biological, and medical device products successfully through the development process. Currently, he serves on the Board of Directors of MMS, Founder/Managing Director of Sun Rock Partners, and an Affiliate Partner at Lindsay Goldberg.
Irving established the Clinical Research Services division at Cytel and served as Senior Vice President of Project Based Services for over 13 years. Prior to Cytel, he held senior leadership roles at Veristat, where he established and oversaw several core business units.
Earlier in his career, Irving held key positions at PAREXEL, where he managed Phase I - III clinical trials in the US, South America, Europe, and Asia. Major therapeutic areas of projects included: lipid-lower agent (CRESTOR®), HIV (NELFINAVIR®), acromegaly (SOMATULINE®), and Stroke.
Irving has an in-depth knowledge of clinical development and biometrics, is a co-author of numerous published clinical studies, and is a DIA invited speaker.
I often use the phrase “Leadership Journey” since there’s no finish line to cross or ultimate goal to achieve. Becoming an effective manager or inspiring leader is a process. A process of learning, evolving, refining, and improving.
Jim Baker
Jim’s experience spans four decades of increasing complexity and leadership responsibilities almost exclusively in the biometrics domain of Clinical Development. The first decade was dedicated to programming code and producing macros initially in financial analytics and quickly shifted to biometrics for new drug development. The technical emphasis was followed by a shift into entry level management expanding to executive leadership over time. His position at Amgen as an Executive Director required building and developing a global Statistical Programming department that continuously expanded through merger and acquisition during his tenure of almost 10 years. Another decade as Senior Vice President at Cytel, a bioanalytical consulting company, focused on creating and expanding a global services group from conception to a major proportion of the company’s revenues. Responsibilities included producing annual budgets and delivering on P&L metrics and targets. Half of his career was operating within pharmaceutical and biotechnology corporations (Amgen, Millennium, Wyeth, Knoll) and the other half providing consulting services to the industry through Clinical Research Organizations (Covance, PAREXEL, Cytel). Truly this is a career from macros as a Statistical Programmer to management as a Senior Vice President and every level in between.